Mawer Investment Management Ltd. Lowers Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Mawer Investment Management Ltd. reduced its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 583,500 shares of the company's stock after selling 44,939 shares during the period. Mawer Investment Management Ltd. owned about 0.22% of Ryan Specialty worth $37,437,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in RYAN. Vanguard Group Inc. lifted its holdings in Ryan Specialty by 5.7% during the fourth quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after purchasing an additional 529,631 shares in the last quarter. State Street Corp lifted its stake in shares of Ryan Specialty by 1.5% during the 3rd quarter. State Street Corp now owns 3,273,093 shares of the company's stock valued at $217,301,000 after buying an additional 49,198 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Ryan Specialty by 0.4% in the 3rd quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company's stock worth $209,058,000 after buying an additional 13,986 shares during the period. Blair William & Co. IL increased its stake in Ryan Specialty by 0.6% in the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after buying an additional 16,540 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after acquiring an additional 981,505 shares during the period. 84.82% of the stock is currently owned by institutional investors.

Remove Ads

Ryan Specialty Trading Up 1.8 %

RYAN traded up $1.33 on Wednesday, hitting $75.14. The company had a trading volume of 1,359,570 shares, compared to its average volume of 932,904. Ryan Specialty Holdings, Inc. has a 12-month low of $48.48 and a 12-month high of $78.67. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The business's fifty day simple moving average is $69.03 and its 200 day simple moving average is $68.46. The company has a market cap of $19.68 billion, a PE ratio of 108.90, a PEG ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.64%. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty's dividend payout ratio is presently 69.57%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. UBS Group upped their price objective on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Wells Fargo & Company lifted their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Morgan Stanley began coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price on the stock. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research note on Friday, February 21st. Finally, Royal Bank of Canada decreased their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Ryan Specialty presently has a consensus rating of "Hold" and a consensus target price of $75.27.

Insider Activity at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the company's stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the completion of the transaction, the director now owns 45,409 shares in the company, valued at $2,954,309.54. This represents a 39.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 241,360 shares of company stock worth $16,006,428. Insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.